IP Library Granted Patent US 9,139,867
Granted Patent B2
US 9,139,867 · App. 14/162,313 · Granted Sep 22, 2015

Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays

Inventors: Bryan Moyer (Moorpark, CA); Albert Zlotnik (San Diego, CA); Peter Hevezi (Encinitas, CA); Hortensia Soto (San Diego, CA); Dalia Kalabat (El Cajon, CA); Min Lu (San Diego, CA); Na Gao (Saint Louis, MO); Evan Carl White (Fair Oaks, CA)
Assignee: SENOYMX, INC.
C12Q1/6806C12Q1/6883C40B30/04C40B40/10G01N33/5044G01N33/566G01N33/6872C12Q2600/158G01N2333/726G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,139,867
App. No.
14/162,313
Granted
Sep 22, 2015
Kind
B2
Abstract

This invention relates to novel rationale and methods for identifying human and primate taste-specific genes, including genes involved in salty taste perception, especially human salty taste perception, but also genes involved in sweet, bitter, umami, and sour taste perception, and genes involved in other taste cell or taste receptor related activities such as digestive function and digestive related diseases, taste cell turnover, immunoregulation of the oral and digestive tract, and metabolic regulation such as in diabetes and obesity, the genes identified using these methods, and assays for identifying taste modulators (enhancers or blockers) and potential therapeutics using these genes. These compounds have potential application in modulating (enhancing or blocking) taste perception, especially salty taste perception and as potential therapeutics. In addition, this invention relates to novel methods for identifying taste-specific genes that can be used as markers for different taste cell types, including sweet, bitter, umami, sour, salty, and other taste cells in mammals as well as assays that measure the activity of the sweet, bitter, umami, or sour receptor in the presence of these genes to identify modulators of sweet, bitter, umami, and sour taste and to identify therapeutics especially for treating digestive or metabolic disorders, taste loss, and oral infections. Particularly, the genes identified herein and antibodies or oligos thereto can be used as markers to identify and/or purify specific taste cells e.g., from taste cell suspensions by use of FACS or magnetic bead cell selection or other known cell purification and isolation procedures.

Claims (11)

1. A composition containing purified human or non-human primate taste cell population, wherein the purified taste cells all express TMEM16G and TRPM5, and further containing at least one compound which is to be assayed for its effect on taste transduction and at least one other moiety that facilitates the detection of the effect of said compound on taste transduction.

2. The composition containing the purified taste cell population of claim 1 , wherein the purified taste cells are human or macaque taste cells.

3. The composition containing the purified taste cell population of claim 1 , wherein the purified taste cells do not express a T1R or a T2R.

4. The composition containing the purified taste cell population of claim 1 , wherein the purified taste cells express transducin or gustducin.

5. The composition containing the isolated cells of claim 1 , which are purified from human or non-human primate circumvallate papilla cells.

6. A method of isolating taste cells that express TMEM16G and TRPM5, comprising:

(i) contacting an impure human or macaque population of cells with a probe that specifically detects taste cells which express TMEM16G; and

(ii) separating the detected TMEM16G-expressing taste cells from the impure cell population, wherein the isolated cells express TMEM16G and TRPM5.

7. The method of claim 6 , wherein the isolated cells which express TMEM16G and TRPM5-expressing taste cells are separated by FACS or magnetic bead cell separation.

8. The method of claim 6 , wherein the purified taste cells are human or macaque taste cells.

9. The method of claim 6 , wherein the isolated cells are purified from human or non-human primate circumvallate papilla cells.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2021
From: MOYER, BRYAN; ZLOTNIK, ALBERT; HEVEZI, PETER; SOTO, HORTENSIA; KALABAT, DALIA; LU, MIN; GAO, NA; WHITE, EVAN CARL
To: SENOMYX, INC.
Reel/Frame 055262/0562 →
MERGER Recorded Feb 15, 2021
From: SENOMYX, INC.
To: FIRMENICH INCORPORATED
Reel/Frame 055262/0579 →
Continuity (17)
Division 13090335 · Apr 20, 2011
Division 12134302 · Jun 6, 2008
Provisional Application 60929017 · Jun 8, 2007
Provisional Application 60929007 · Jun 8, 2007
Provisional Application 60947052 · Jun 29, 2007
Provisional Application 60935297 · Aug 3, 2007
Provisional Application 60987611 · Nov 13, 2007
Provisional Application 60988938 · Nov 19, 2007
Provisional Application 60991274 · Nov 30, 2007
Provisional Application 60991289 · Nov 30, 2007
Provisional Application 60992502 · Dec 5, 2007
Provisional Application 60992517 · Dec 5, 2007
Provisional Application 61017244 · Dec 28, 2007
Provisional Application 61021437 · Jan 16, 2008
Provisional Application 61043257 · Apr 8, 2008
Provisional Application 61053310 · May 15, 2008
Related Publication 20140206004A1 · Jul 24, 2014